Pure Global AI
NCT06312735Recruiting

VR for Patients With Chronic Pain (Wait & Work)

Cluster-randomized Controlled Trial of Virtual Reality for Patients With Chronic Musculoskeletal Pain (Wait & Work)
University of TwenteClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Chronic Pain
Drug/Device/Intervention
VR (Reducept)
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Twente
Location
Emmeloord,Deventer,Enschede,Hengelo, Netherlands
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2023
End date
Sep 30, 2024
Enrollment
60 participants
Primary outcome

Change in quality of life measured using the short-form 12 (SF-12)

Summary

This cluster-RCT evaluates the effect of therapeutic virtual reality (VR) on patients with
 chronic musculoskeletal pain (CMP) who are on a waiting list to receive pain treatment. The
 used VR application, Reducept, offers pain education and pain management techniques. This
 home-based, stand-alone, immersive VR intervention was used daily for four weeks in the
 intervention group. The control group received standard care (no treatment). Primary outcome
 measure for this study was health-related quality of life, secondary outcome measures
 included various pain-related variables (e.g. pain self-efficacy and acceptance. Outcome
 variables will be measured after four weeks and follow-up after six months.

ICD-10 classifications
Other chronic painChronic intractable painPain, not elsewhere classifiedPain, unspecifiedPain associated with micturition
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06312735
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06312735 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Twente and is currently Recruiting. The study focuses on Chronic Pain. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.